ArticleToxicology reports2026
Presence of glyphosate in endometrial cancer tissue: A cross-sectional study.
Article in Toxicology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Glyphosate (GLY), a widely used herbicide classified as a probable human carcinogen, has an unclear role in hormone-dependent malignancies. This cross-sectional study investigated the presence and elevated concentration of this compound in endometrial tissues and its potential link to uterine cancers, also exploring interactions with other natural environmental contaminants such as mycotoxin Zearalenone (ZEN). Patients with endometrial cancers and age- and Body Mass Index-matched controls with benign endometrial diseases were recruited. Serum and excised endometrial tissue samples were analyzed for GLY, ZEN, and related physiological-hormonal indicators. Results revealed significantly elevated serum GLY levels in patients with high-grade endometrial cancer compared to controls (p < 0.05). Similarly, endometrial tissues from cancer patients, particularly those with high-grade malignancy, exhibited higher GLY levels than controls. Notably, GLY concentrations were significantly greater in endometrial tissue than in serum across all participant groups. No significant correlations were found between hormonal/physiological indicators and GLY levels. A strong positive correlation was observed between endometrial GLY and ZEN levels. This study is among the first to detect the presence and elevated concentration of GLY in human endometrial tissue, raising concerns that GLY exposure may be a significant factor in hormone-dependent diseases, particularly those mediated by estrogen or estrogen-like substances. The findings also highlight the need for further research into the endocrine-disrupting effects and long-term health consequences of GLY and various mycotoxins, as well as their potential synergistic involvement in the development of uterine cancers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.